PUMA BIOTECHNOLOGY, INC. Quarterly Operating Margin in % from Q2 2018 to Q2 2024

Taxonomy & unit
ratio: %
Description
The operating margin measures the profit a company makes on a dollar of sales after accounting for the direct costs involved in earning those revenues.
Summary
Puma Biotechnology, Inc. quarterly/annual Operating Margin history and growth rate from Q2 2018 to Q2 2024.
  • Puma Biotechnology, Inc. Operating Margin for the quarter ending June 30, 2024 was 8.63 %, a 8.39% decline year-over-year.
Operating Margin, Quarterly (%)
Operating Margin, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q2 2024 8.63 -0.79 -8.39% Apr 1, 2024 Jun 30, 2024
Q1 2024 11.5 -0.8 -6.52% Jan 1, 2024 Mar 31, 2024
Q4 2023 13.9 +3.45 +33.2% Oct 1, 2023 Dec 31, 2023
Q3 2023 12.2 +2.77 +29.5% Jul 1, 2023 Sep 30, 2023
Q2 2023 9.42 +5.02 +114% Apr 1, 2023 Jun 30, 2023
Q1 2023 12.3 +22 Jan 1, 2023 Mar 31, 2023
Q4 2022 10.4 +9.89 +1941% Oct 1, 2022 Dec 31, 2022
Q3 2022 9.39 +16 Jul 1, 2022 Sep 30, 2022
Q2 2022 4.39 +12.2 Apr 1, 2022 Jun 30, 2022
Q1 2022 -9.77 -11.2 -765% Jan 1, 2022 Mar 31, 2022
Q4 2021 0.51 +14 Oct 1, 2021 Dec 31, 2021
Q3 2021 -6.63 +5.23 +44.1% Jul 1, 2021 Sep 30, 2021
Q2 2021 -7.76 +4.79 +38.2% Apr 1, 2021 Jun 30, 2021
Q1 2021 1.47 +29.6 Jan 1, 2021 Mar 31, 2021
Q4 2020 -13.5 +0.84 +5.86% Oct 1, 2020 Dec 31, 2020
Q3 2020 -11.9 +5.59 +32% Jul 1, 2020 Sep 30, 2020
Q2 2020 -12.5 +3.42 +21.4% Apr 1, 2020 Jun 30, 2020
Q1 2020 -28.1 -6.48 -29.9% Jan 1, 2020 Mar 31, 2020
Q4 2019 -14.3 +23.4 +62% Oct 1, 2019 Dec 31, 2019
Q3 2019 -17.4 +51.9 +74.8% Jul 1, 2019 Sep 30, 2019
Q2 2019 -16 +126 +88.8% Apr 1, 2019 Jun 30, 2019
Q1 2019 -21.7 Jan 1, 2019 Mar 31, 2019
Q4 2018 -37.7 Oct 1, 2018 Dec 31, 2018
Q3 2018 -69.3 Jul 1, 2018 Sep 30, 2018
Q2 2018 -142 Apr 1, 2018 Jun 30, 2018
* An asterisk sign (*) next to the value indicates that the value is likely invalid.